Sonoma Pharmaceuticals (SNOA) Receivables - Other (2012 - 2016)
Sonoma Pharmaceuticals (SNOA) posted quarterly Receivables - Other of $912000.0 for Q1 2016, up 8.19% year-over-year from $843000.0 in Q2 2015, and up 8.19% quarter-over-quarter from $843000.0 in Q1 2015.
Sonoma Pharmaceuticals (SNOA) Receivables - Other (2012 - 2016) Analysis & Trends
Sonoma Pharmaceuticals' Receivables - Other history runs 5 years deep, the most recent figure standing at $912000.0 for Q1 2016.
- In Q1 2016, Receivables - Other rose 8.19% year-over-year to $912000.0; the TTM figure through Mar 2016 stood at $912000.0 (up 8.19% YoY), while the FY2016 annual figure was $912000.0, up 8.19% from the prior year.
- Receivables - Other for Q1 2016 stood at $912000.0, up from $843000.0 in the prior quarter.
- The five-year high for Receivables - Other was $912000.0 in Q1 2016, with the low at $264000.0 in Q1 2013.
- The 5-year median for Receivables - Other is $439000.0 (2012), against an average of $533142.9.
- The sharpest annual moves came in 2013 and 2014: Receivables - Other slipped 8.97% in 2013, then jumped 130.68% in 2014.
- Sonoma Pharmaceuticals' Receivables - Other stood at $439000.0 in 2012, then sank by 39.86% to $264000.0 in 2013, then jumped by 130.68% to $609000.0 in 2014, then soared by 38.42% to $843000.0 in 2015, then climbed by 8.19% to $912000.0 in 2016.
- Business Quant data shows SNOA's Receivables - Other at $912000.0 in Q1 2016, $843000.0 in Q1 2015, and $609000.0 in Q1 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 912,000.00 |
| Mar 31, 2016 | 912,000.00 |
| Mar 31, 2015 | 843,000.00 |
| Mar 31, 2015 | 843,000.00 |
| Mar 31, 2014 | 609,000.00 |
| Mar 31, 2014 | 609,000.00 |
| Mar 31, 2013 | 264,000.00 |
| Mar 31, 2013 | 264,000.00 |
| Dec 31, 2012 | 439,000.00 |
| Dec 31, 2012 | 439,000.00 |
| Sep 30, 2012 | 375,000.00 |
| Sep 30, 2012 | 375,000.00 |
| Mar 31, 2012 | 290,000.00 |
| Mar 31, 2012 | 290,000.00 |